An extra hour of sleep is on the way for most Americans, though the "fall back" to standard time will bring darker afternoons ...

A nurse was killed and a health worker severely injured after being attacked while responding to an Ebola alert in Congo, ...

Patients with heavily pretreated hormone receptor (HR)-positive breast cancer lived twice as long without disease progression with the novel antibody-drug conjugate (ADC) izalontamab brengitecan ...

"The cat is out of the bag." -- Adam Waickman, PhD, of SUNY Upstate Medical University in Syracuse, New York, discussing the ...

Heart attacks are largely preventable, and we have had the means to find the disease and treat it in time for more than a ...

Until recently, a Manhattanite might venture no more than a few dozen blocks to find the world's most sophisticated cancer ...

Significant proteinuria reductions were reported in phase III interim analyses assessing two investigational IgA nephropathy ...

Perioperative treatment with durvalumab (Imfinzi) plus neoadjuvant enfortumab vedotin (EV) significantly improved event-free survival (EFS) and overall survival (OS) compared with radical cystectomy ...

For medium vessel occlusion strokes, perfusion mismatch ratio predicted follow-up infarct volume, a multinational trial showed, supporting a role similar to that in large vessel occlusion. In the 94 ...

Tennessee execution team members failed multiple times to establish working IV lines in Christa Pike's arms before her attempted execution and warned that some of her veins may have ruptured, or ...

Overall survival (OS) in extensive-stage small-cell lung cancer (ES-SCLC) approached 2 years with tarlatamab (Imdelltra) combination maintenance therapy after first-line chemoimmunotherapy, a large ...